Reuters Health Report: December 22, 2016

Click to View in Browser Thursday, December 22, 2016 Roche's emicizumab haemophilia drug succeeds in trial ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday. Texas moves to cut Medicaid funding for Planned Parenthood AUSTIN, Texas (Reuters) - Texas plans to block about $3 million in Medicaid funding for Planned Parenthood operations in the state, a legal document obtained on Wednesday showed, a move the reproductive healthcare group said could affect nearly 11,000 low-income people. North Carolina rebuffs transgender bathroom law repeal RALEIGH, N.C. (Reuters) - North Carolina's Republican-controlled legislature on Wednesday rejected a bid to repeal a state law restricting bathroom access for transgender people, which has drawn months of protests and boycotts by opponents decrying the measure as discriminatory. U.S. says 6.4 million signed up for Obamacare from November 1: Dec. 19 NEW YORK (Reuters) - Roughly 6.4 million consumers signed up for Obamacare insurance on Healthcare.gov from Nov. 1 to Dec. 19 indicating "clear demand for quality, affordable coverage," the U.S. government said on Wednesday. China confirms third human bird flu infection, stirs fears of spread BEIJING (Reuters) - China has found two more cases of human bird flu infection, bringing this week's total to three and stoking fears the deadly virus could spread at a time when other Asian nations are battling to control outbreaks of the disease. Body image problems in teen girls tied to alcohol use High school girls who have issues with body image and weight are more likely to be drinkers than ) their peers, a recent U.S. study suggests. Inovio Zika vaccine evokes robust response in early human study (Reuters) - Inovio Pharmaceuticals Inc said its experimental Zika vaccine induced robust immune responses in an early-stage study in human volunteers who have not been infected with the virus. Brazil's Hypermarcas in talks to sell diaper unit to Belgium's Ontex SAO PAULO (Reuters) - Belgium's Ontex Group NV said on Thursday it is in advanced talks to buy the diapers business of Hypermarcas SA , Brazil's most diversified pharmaceutical firm. Investors see Biogen CEO choice as friendly to potential takeover NEW YORK (Reuters) - The surprise selection of Michel Vounatsos to run Biogen Inc signals a shift toward a more commercial management focus after years of targeting ambitious scientific gains, and likely keeps the U.S. biotech in play as a takeover target. Colombia cuts price of Novartis cancer drug by 44 percent BOGOTA (Reuters) - Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs after failed price negotiations with the Swiss company. Related Video Former Flint officials charged in water crisis Mini-factories could allow drug production on Mars, say researchers A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2016 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook